CapsoVision (CV) Change in Account Payables (2024 - 2025)

CapsoVision's (CV) quarterly Change in Account Payables came in at -$220000.0 in Q4 2025, down 235.8% year-on-year from $162000.0 in Q4 2024, and down 217.02% quarter-over-quarter from $188000.0 in Q3 2025.

CapsoVision (CV) Change in Account Payables (2024 - 2025) Analysis & Trends

CapsoVision has disclosed Change in Account Payables across 2 years of filings, most recently posting -$220000.0 for Q4 2025.

  • Change in Account Payables for Q4 2025 came in at -$220000.0, down 235.8% year-over-year; the trailing twelve-month figure through Dec 2025 was -$13000.0 (changed N/A YoY), and the FY2025 annual result was $376000.0, down 3.09% from the prior year.
  • Change in Account Payables came in at -$220000.0 for Q4 2025 at CapsoVision, down from $188000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $188000.0 in Q3 2025 to a low of -$220000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -198.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 221.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 56.90 Mn
10 CapsoVision 161.82 Mn 151.71 Mn 1.95 Mn -220,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -220,000.00
Dec 31, 2025 -220,000.00
Sep 30, 2025 188,000.00
Sep 30, 2025 188,000.00
Dec 31, 2024 162,000.00
Dec 31, 2024 162,000.00
Sep 30, 2024 -143,000.00
Sep 30, 2024 -143,000.00